Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0H5XR
|
||||
Former ID |
DNC008386
|
||||
Drug Name |
YM-348
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [539452] | ||
Structure |
Download2D MOL |
||||
Formula |
C14H17N3O
|
||||
InChI |
InChI=1S/C14H17N3O/c1-3-11-6-12-13(18-11)5-4-10-7-16-17(14(10)12)8-9(2)15/h4-7,9H,3,8,15H2,1-2H3/t9-/m0/s1
|
||||
InChIKey |
QLOOWOVVZLBYHU-VIFPVBQESA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | 5-hydroxytryptamine 2A receptor | Target Info | Inhibitor | [529221] | |
5-hydroxytryptamine 2B receptor | Target Info | Inhibitor | [529221] | ||
5-hydroxytryptamine 2C receptor | Target Info | Inhibitor | [529221] | ||
WikiPathways | Serotonin Receptor 2 and STAT3 Signaling | ||||
Serotonin Receptor 2 and ELK-SRF/GATA4 signaling | |||||
SIDS Susceptibility Pathways | |||||
Monoamine GPCRs | |||||
GPCRs, Class A Rhodopsin-like | |||||
Gastrin-CREB signalling pathway via PKC and MAPK | |||||
GPCR ligand binding | |||||
GPCR downstream signaling | |||||
GPCRs, OtherWP732:Serotonin Receptor 2 and ELK-SRF/GATA4 signaling | |||||
GPCR downstream signalingWP732:Serotonin Receptor 2 and ELK-SRF/GATA4 signaling | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.